Invention Grant
- Patent Title: Compositions and methods for diagnosis and treatment of cancer
-
Application No.: US15552215Application Date: 2016-03-15
-
Publication No.: US10370433B2Publication Date: 2019-08-06
- Inventor: Ugur Sahin , Joycelyn Wüstehube-Lausch , Markus Fiedler , Matin Daneschdar , Hans-Ulrich Schmoldt
- Applicant: BIONTECH AG
- Applicant Address: DE Mainz
- Assignee: Biontech AG
- Current Assignee: Biontech AG
- Current Assignee Address: DE Mainz
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/EP2016/055601 WO 20160315
- International Announcement: WO2016/146639 WO 20160922
- Main IPC: C07K14/81
- IPC: C07K14/81 ; C07K14/00 ; C07K5/10
Abstract:
The present invention relates to the diagnosis and treatment of cancerous diseases, in particular cancerous diseases expressing Seprase (Fap-alpha; fibroblast activation protein alpha). More particularly, the invention concerns peptides targeting Seprase.
Public/Granted literature
- US20180037632A1 Compositions and Methods for Diagnosis and Treatment of Cancer Public/Granted day:2018-02-08
Information query
